June 9th 2010 at 12.15 pm
Mediteknia auditorium, Kuopio Campus
12.15 Professor Kai Simons: Cell membranes in physiology and disease
13.15 Professor Ole Petter Ottersen: TBA
15.00 Professor Per Artursson: Predictions of drug-drug interactions with transport proteins
16.00 Professor John F. Martin: Stem cell or gene therapy: which will be the future of therapeutics
The seminar is open to all.
The lecturers of the seminar will receive the award of Honorary Doctor in the Conferment Ceremonies June 10-12th, 2010.
Professor John Martin has been chosen as Doctor of Medicine H.C. He works as Professor of Cardiovascular Medicine at University College London. Professor Martin is a highly respected consultant physician and researcher of cardiovascular diseases. He has, among other things, made original discoveries of the significance of platelet production in myocardial infarction and the role of vascular endothelial growth factor VEGF in protecting the walls of blood vessels.
Professor Ole Petter Ottersen has been chosen as Doctor of Medicine H.C. Ole PetterOttersen is Professor of Medicine and Rector (President) of the University of Oslo. Professor Ottersen is recognized for his outstanding research in molecular neuroscience. His current research focuses on investigating molecular mechanisms involved in the development of acute and chronic neurodegenerative disease, with a special emphasis on the role of cellular water balance and glutamate excitotoxicity.
Professor Per Artursson has been chosen as Doctor of Pharmacy H.C. Per Artursson works as Professor of Dosage Form Design at the Department of Pharmacy, Uppsala University. He has made a significant career in the research of pharmacy, especially in drug absorption, disposition and delivery. He has made globally pioneering research contributions in the development of in vitro models for the prediction of drug absorption through small intestine.
Professor Kai Simons has been chosen as Doctor of Medicine H.C. Professor Simons works as Group leader at the Max-Planck-Institute of Molecular Cell Biology and Genetics in Dresden. Until 2006 he was also Director of the same Institute. Before the Max Planck Institute, he made a long career in European Molecular Biology Laboratory (EMBL) in Heidelberg, starting a cell biology research program, which developed into a leading European cell biology research unit.
Publishing year: 2010Back to this years article listing